Markets

Health Care Sector Update for 12/23/2015: EYG, ITCI

Top Health-care stocks:

JNJ: +0.6%

PFE: +0.4%

ABT: flat

MRK: flat

AMGN: flat

Health-care shares were mainly unchanged in pre-market trade on Wednesday.

In health-care stocks news, Eyegate Pharmaceuticals ( EYEG ) shares were initiated by Chardan with a buy rating and price target of $6 per share.

Shares in the company were unchanged at $2.50 pre-bell. This is within the lower band of the stock's 52 week trading range between $2.39 and $27.

And Intra-Cellular Therapies ( ITCI ) announced that it has started enrollment for the Phase 3 clinical trials in its bipolar depression program.

Shares in the company were flat at $52.66. This is within the upper band of the stock's 52 week trading range between $16.27 and $60.79.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ITCI EYEG

Other Topics

Commodities

Latest Markets Videos

    MTNewswires

    Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the largest banks, brokerage firms and professional market data, trading & research applications in North America.

    Learn More